Patents by Inventor Charles A. Richardson

Charles A. Richardson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10172930
    Abstract: Methods for purifying human Calciviruses are disclosed, including Noroviruses and Sapoviruses.
    Type: Grant
    Filed: May 2, 2016
    Date of Patent: January 8, 2019
    Assignee: TAKEDA VACCINES, INC.
    Inventors: Thomas S. Vedvick, Bryan Steadman, Charles Richardson, Thomas R. Foubert, Charles R. Petrie
  • Patent number: 10130696
    Abstract: The present invention relates to vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to methods of conferring protective immunity to Norovirus infections in a human subject.
    Type: Grant
    Filed: September 18, 2008
    Date of Patent: November 20, 2018
    Assignee: TAKEDA VACCINES, INC.
    Inventors: Charles Richardson, Thomas S. Vedvick, Thomas R. Foubert, William Tino
  • Publication number: 20180185468
    Abstract: The present invention relates to single dose parental vaccine compositions comprising mixtures of monovalent Norovirus virus-like particles. Methods of conferring protective immunity against Norovirus infections in a human subject by administering such compositions are also disclosed.
    Type: Application
    Filed: December 8, 2017
    Publication date: July 5, 2018
    Inventors: Charles RICHARDSON, Thomas R. FOUBERT
  • Patent number: 10010599
    Abstract: The present invention relates to antigenic and vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to a process for the production of both monovalent and multivalent VLPs, the VLPs comprising capsid proteins from one or more Norovirus genogroups.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: July 3, 2018
    Assignee: TAKEDA VACCINES, INC.
    Inventors: Charles Richardson, Thomas S. Vedvick, Thomas R. Foubert, William T. Tino
  • Patent number: 9867876
    Abstract: The present invention relates to single dose parenteral vaccine compositions comprising mixtures of monovalent Norovirus virus-like particles. Methods of conferring protective immunity against Norovirus infections in a human subject by administering such compositions are also disclosed.
    Type: Grant
    Filed: July 10, 2015
    Date of Patent: January 16, 2018
    Assignee: Takeda Vaccines, Inc.
    Inventors: Charles Richardson, Thomas R. Foubert
  • Patent number: 9861691
    Abstract: The present invention relates to antigenic and vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to a process for the production of both monovalent and multivalent VLPs, the VLPs comprising capsid proteins from one or more Norovirus genogroups.
    Type: Grant
    Filed: July 10, 2015
    Date of Patent: January 9, 2018
    Assignee: Takeda Vaccines, Inc.
    Inventors: Charles Richardson, Thomas S. Vedvick, Thomas R. Foubert, William T. Tino
  • Patent number: 9821049
    Abstract: The present invention relates to vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to methods of conferring protective immunity to Norovirus infections in a human subject.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: November 21, 2017
    Assignee: Takeda Vaccines, Inc.
    Inventors: Charles Richardson, Thomas S. Vedvick, Thomas R. Foubert, Robert F. Bargatze, William Tino
  • Patent number: 9801934
    Abstract: The present invention relates to single dose parenteral vaccine compositions comprising mixtures of monovalent Norovirus virus-like particles. Methods of conferring protective immunity against Norovirus infections in a human subject by administering such compositions are also disclosed.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: October 31, 2017
    Assignee: TAKEDA VACCINES, INC.
    Inventors: Charles Richardson, Thomas R. Foubert
  • Patent number: 9731216
    Abstract: A flying disc includes a hub composed of polymeric material, a ring composed of polymeric material and coupled to the hub. The hub and the ring may have different specific gravities by being composed of different materials or by having a weighting product embedded therein, or a weighting product may be carried between the hub and the ring.
    Type: Grant
    Filed: June 20, 2011
    Date of Patent: August 15, 2017
    Assignee: MVP Disc Sports, LLC
    Inventors: Brad Charles Richardson, Chad Michael Richardson
  • Patent number: 9518096
    Abstract: The present invention provides polypeptides having a composite amino acid sequence derived from a consensus sequence representing the capsid proteins of two or more circulating strains of a non-enveloped virus. In particular, the invention provides virus-like particles comprising at least one composite polypeptide. Such virus-like particles have antigenic epitopes of two or more circulating strains of a non-enveloped virus and produce an increase in antisera cross-reactivity to one or more circulating strains of the non-enveloped virus. Methods of making composite virus-like particles and vaccine formulations comprising composite virus-like particles are also disclosed.
    Type: Grant
    Filed: July 25, 2014
    Date of Patent: December 13, 2016
    Assignee: TAKEDA VACCINES, INC.
    Inventors: Charles Richardson, Robert F. Bargatze, Joel Haynes, Bryan Steadman
  • Publication number: 20160317645
    Abstract: Methods for purifying human Calciviruses are disclosed, including Noroviruses and Sapoviruses.
    Type: Application
    Filed: May 2, 2016
    Publication date: November 3, 2016
    Inventors: Thomas S. VEDVICK, Bryan STEADMAN, Charles RICHARDSON, Thomas R. FOUBERT, Charles R. PETRIE
  • Patent number: 9359410
    Abstract: Methods for purifying human Calciviruses are disclosed, including Noroviruses and Sapoviruses.
    Type: Grant
    Filed: June 10, 2013
    Date of Patent: June 7, 2016
    Assignee: TAKEDA VACCINES INC.
    Inventors: Thomas S. Vedvick, Bryan Steadman, Charles Richardson, Thomas R. Foubert, Charles R. Petrie
  • Patent number: 9308249
    Abstract: The present invention relates to antigenic and vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to a process for the production of both monovalent and multivalent VLPs, the VLPs comprising capsid proteins from one or more Norovirus genogroups.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: April 12, 2016
    Assignee: TAKEDA VACCINES, INC.
    Inventors: Charles Richardson, Thomas S. Vedvick, Thomas R. Foubert, William T. Tino
  • Patent number: 9272028
    Abstract: The present invention relates to antigenic and vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to a process for the production of both monovalent and multivalent VLPs, the VLPs comprising capsid proteins from one or more Norovirus genogroups.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: March 1, 2016
    Assignee: TAKEDA VACCINES, INC.
    Inventors: Charles Richardson, Thomas S. Vedvick, Thomas R. Foubert, William T. Tino
  • Publication number: 20160008455
    Abstract: The present invention relates to antigenic and vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to a process for the production of both monovalent and multivalent VLPs, the VLPs comprising capsid proteins from one or more Norovirus genogroups.
    Type: Application
    Filed: July 10, 2015
    Publication date: January 14, 2016
    Inventors: Charles RICHARDSON, Thomas S. VEDVICK, Thomas R. FOUBERT, William T. TINO
  • Publication number: 20160000899
    Abstract: The present invention relates to single dose parenteral vaccine compositions comprising mixtures of monovalent Norovirus virus-like particles. Methods of conferring protective immunity against Norovirus infections in a human subject by administering such compositions are also disclosed.
    Type: Application
    Filed: July 10, 2015
    Publication date: January 7, 2016
    Inventors: Charles RICHARDSON, Thomas R. FOUBERT
  • Publication number: 20150023995
    Abstract: The present invention provides polypeptides having a composite amino acid sequence derived from a consensus sequence representing the capsid proteins of two or more circulating strains of a non-enveloped virus. In particular, the invention provides virus-like particles comprising at least one composite polypeptide. Such virus-like particles have antigenic epitopes of two or more circulating strains of a non-enveloped virus and produce an increase in antisera cross-reactivity to one or more circulating strains of the non-enveloped virus. Methods of making composite virus-like particles and vaccine formulations comprising composite virus-like particles are also disclosed.
    Type: Application
    Filed: July 25, 2014
    Publication date: January 22, 2015
    Applicant: TAKEDA VACCINES, INC.
    Inventors: Charles RICHARDSON, Robert F. BARGATZE, Joel HAYNES, Bryan STEADMAN
  • Publication number: 20140286994
    Abstract: The present invention relates to antigenic and vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to a process for the production of both monovalent and multivalent VLPs, the VLPs comprising capsid proteins from one or more Norovirus genogroups.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 25, 2014
    Inventors: Charles RICHARDSON, Thomas S. VEDVICK, Thomas R. FOUBERT
  • Patent number: 8841120
    Abstract: The present invention provides polypeptides having a composite amino acid sequence derived from a consensus sequence representing the capsid proteins of two or more circulating strains of a non-enveloped virus. In particular, the invention provides virus-like particles comprising at least one composite polypeptide. Such virus-like particles have antigenic epitopes of two or more circulating strains of a non-enveloped virus and produce an increase in antisera cross-reactivity to one or more circulating strains of the non-enveloped virus. Methods of making composite virus-like particles and vaccine formulations comprising composite virus-like particles are also disclosed.
    Type: Grant
    Filed: February 8, 2011
    Date of Patent: September 23, 2014
    Assignee: Takeda Vaccines, Inc.
    Inventors: Charles Richardson, Robert F. Bargatze, Joel Haynes, Bryan Steadman
  • Publication number: 20130344107
    Abstract: Methods for purifying human Calciviruses are disclosed, including Noroviruses and Sapoviruses.
    Type: Application
    Filed: June 10, 2013
    Publication date: December 26, 2013
    Inventors: THOMAS S. VEDVICK, BRYAN STEADMAN, CHARLES RICHARDSON, THOMAS R. FOUBERT, CHARLES R. PETRIE